SCHEMBL7573680

SCHEMBL7573680

CCOC(=O)C(OCC)N1C=CCN(C(OCC)C(=O)OCC)C1=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6079010 0.63 ALDH1A1 (0.41) LMNASMN1; SMN2
SCHEMBL6029302 0.62 ALDH1A1 (0.48) LMNASMN1; SMN2
SCHEMBL8919481 0.61 ALDH1A1 (0.46) LMNA
SCHEMBL27461888 0.61 ALDH1A1 (0.40) LMNASMN1; SMN2
SCHEMBL27360345 0.59 ALDH1A1 (0.38) LMNA
SCHEMBL6516867 0.58 PPARA (0.33)
Hydrochloric Acid SCHEMBL7953553 0.58 ALDH1A1 (0.37) LMNASMN1; SMN2
SCHEMBL8026320 0.58 CYP2D6 (0.38) LMNA
SCHEMBL5573133 0.57 ALDH1A1 (0.44) LMNASMN1; SMN2
SCHEMBL3209999 0.57 TSHR (0.41) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0976738-B1 Process for the preparation of propylene ureas DAINIPPON INK & CHEMICALS (JP) 2002-12-04 EP disclosed
US-6348594-B2 HARDENING OF POLYMERS DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-02-19 US disclosed
US-20020004599-A1 PROPYLENE UREAS AND PROCESS FOR THEIR PREPARATION. DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-01-10 US disclosed
EP-0976738-A2 Propylene ureas and the process for their preparation DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020004599-A1 PROPYLENE UREAS AND PROCESS FOR THEIR PREPARATION. UQCRB, URB2, ADH1C LMNA 1238/4885SMN1; SMN2 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.